Cargando…
Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases
BACKGROUND: Assays of molecular biomarkers in urine are non-invasive compared to other body fluids and can be easily repeated. Based on the hypothesis that the secreted markers from the diseased organs may locally release into the body fluid in the vicinity of the injury, urine-based assays have bee...
Autores principales: | Chen, Zhaohui, Kim, Jayoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802825/ https://www.ncbi.nlm.nih.gov/pubmed/27000794 http://dx.doi.org/10.1186/s12894-016-0129-7 |
Ejemplares similares
-
Advances in urinary biomarker discovery in urological research
por: Kim, Jayoung, et al.
Publicado: (2020) -
Metabolic profiling of cholesterol and sex steroid hormones to monitor urological diseases
por: Moon, Ju-Yeon, et al.
Publicado: (2016) -
Urobiome: An outlook on the metagenome of urological diseases
por: Shoemaker, Rachel, et al.
Publicado: (2021) -
Metabolomic and lipidomic approaches to identify biomarkers for bladder cancer and interstitial cystitis
por: Shahid, Muhammad, et al.
Publicado: (2020) -
Tissue Engineering and Regenerative Medicine in Pediatric Urology: Urethral and Urinary Bladder Reconstruction
por: Casarin, Martina, et al.
Publicado: (2022)